EFFECTS OF 6R-L-ERYTHRO-5,6,7,8-TETRAHYDROBIOPTERIN ON THE DOPAMINERGIC AND CHOLINERGIC RECEPTORS AS EVALUATED BY POSITRON EMISSION TOMOGRAPHY IN THE RHESUS-MONKEY
Y. Tani et al., EFFECTS OF 6R-L-ERYTHRO-5,6,7,8-TETRAHYDROBIOPTERIN ON THE DOPAMINERGIC AND CHOLINERGIC RECEPTORS AS EVALUATED BY POSITRON EMISSION TOMOGRAPHY IN THE RHESUS-MONKEY, Journal of neural transmission, 102(3), 1995, pp. 189-208
The effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP) on th
e central cholinergic and dopaminergic systems in the Rhesus monkey br
ain were investigated by positron emission tomography (PET) with the m
uscarinic cholinergic receptor ligands (N-[C-11]methyl-benztropine) an
d dopaminergic receptor ligands selective for D-1, D-2, and D-3 subtyp
es ([C-11]SCH23390, N-[C-11]methyl-spiperone, and (+)[C-11]UH232, resp
ectively). None of the doses (3, 10, and 30 mg/kg i.v.) of R-THBP used
significantly affected the regional cerebral blood flow (rCBF as dete
rmined by Raichle's (H2O)-O-15 method), and 10 mg/kg of R-THBP had lit
tle effect on the regional cerebral metabolic rate of glucose (rCMRglc
) in the Rhesus monkey brain, as assessed by the graphical [F-18]fluor
o-deoxyglucose method. The effect of R-THBP on the muscarinic choliner
gic system was dose dependent; while 3 mg/kg of R-THBP did not signifi
cantly alter the uptake ratio of N-[C-11]methyl-benztropine in several
brain regions to that in the cerebellum, 10 and 30 mg/kg of R-THBP si
gnificantly reduced the uptake ratio in the thalamus, as well as in th
e frontal and temporal cortices. None of the doses (3, 10, and 30 mg/k
g i.v.) of R-THBP tested affected [C-11]SCH23390 (dopamine D-1 recepto
r) binding. However, the k3 value for N-[C-11]methyl-spiperone (dopami
ne D-2 receptor) binding, which represents the association rate x B-ma
x value, was significantly decreased in the striatum. The uptake ratio
of (+)[C-11]UH232 (dopamine D-3 receptor) in the striatum to that in
the cerebellum was also decreased by administration of R-THBP (3 and 3
0 mg/kg i.v.). These findings suggest that R-THBP acts on dopamine D-2
and D-3 receptors selectively without markedly affecting dopamine D-1
receptor binding. Furthermore, the changes in cholinergic and dopamin
e D-2 and D-3 receptors in vivo can not be attributed to a change in r
CBF but may depend on the action of R-THBP.